Parameter | Value |
---|---|
N | 22 |
Initial anatomy | Â |
Multiple left heart obstructions | 19 (86%) |
Critical aortic stenosis | 3 (14%) |
Female | 7 (32%) |
In utero aortic valvuloplasty | 9 (40%) |
Age at CMR (mo) | 39 (0–82) |
Body surface area (m2) | 0.59 (0.22-0.72) |
Circulation at the time of CMR | Â |
Prostaglandin infusion | 3 (13%) |
Norwood stage 1 palliation | 2 (9%) |
Hybrid stage 1 palliation | 1 (5%) |
Bidirectional Glenn shunt | 15 (68%) |
Total cavopulmonary connection | 1 (5%) |
Prior procedure to increase left heart flow | 17 (77%) |
Dual sources of pulmonary blood flow | 13 |
Restriction of the atrial septal defect | 16 |
CMR parameters | Â |
Heart rate (beats/min) | 110 (89–150) |
LV EDV (ml/m2) | 57 (21–88) |
LV ESV (ml/m2) | 21 (10–49) |
LV stroke volume (ml/m2) | 31 (4–60) |
LV ejection fraction (%) | 61 (20–79) |
RV EDV (ml/m2) | 82 (52–132) |
RV ESV (ml/m2) | 39 (22–82) |
RV stroke volume (ml/m2) | 42 (17–65) |
RV ejection fraction (%) | 54 (27–66) |
LV-to-RV stroke volume ratio | 0.8 (0.06-1.7) |
MV-to-TV inflow ratio | 1.0 (0.2-3.0) |
LGE pattern consistent with EFE | 16 (73%) |
LA pressure (mm Hg) | 14 (5–16) |
LV ED pressure (mm Hg) | 12 (8–22) |
Biventricular procedure CPB time (min) | 149 (92–239) |
Biventricular procedure LOS (days) | 25 (7–156) |